Dipraglurant

dipraglurant · Addex Pharma S.A.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Dipraglurant, covering 2025-08-06 to 2025-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm [Phase 2]